BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 30232282)

  • 1. A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies.
    Serafini PR; Feyder MJ; Hightower RM; Garcia-Perez D; Vieira NM; Lek A; Gibbs DE; Moukha-Chafiq O; Augelli-Szafran CE; Kawahara G; Widrick JJ; Kunkel LM; Alexander MS
    JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zebrafish models for human FKRP muscular dystrophies.
    Kawahara G; Guyon JR; Nakamura Y; Kunkel LM
    Hum Mol Genet; 2010 Feb; 19(4):623-33. PubMed ID: 19955119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP).
    Thornhill P; Bassett D; Lochmüller H; Bushby K; Straub V
    Brain; 2008 Jun; 131(Pt 6):1551-61. PubMed ID: 18477595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery.
    Qiao C; Wang CH; Zhao C; Lu P; Awano H; Xiao B; Li J; Yuan Z; Dai Y; Martin CB; Li J; Lu Q; Xiao X
    Mol Ther; 2014 Nov; 22(11):1890-9. PubMed ID: 25048216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I.
    Frattini P; Villa C; De Santis F; Meregalli M; Belicchi M; Erratico S; Bella P; Raimondi MT; Lu Q; Torrente Y
    Hum Mol Genet; 2017 Oct; 26(19):3682-3698. PubMed ID: 28666318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FKRP-dependent glycosylation of fibronectin regulates muscle pathology in muscular dystrophy.
    Wood AJ; Lin CH; Li M; Nishtala K; Alaei S; Rossello F; Sonntag C; Hersey L; Miles LB; Krisp C; Dudczig S; Fulcher AJ; Gibertini S; Conroy PJ; Siegel A; Mora M; Jusuf P; Packer NH; Currie PD
    Nat Commun; 2021 May; 12(1):2951. PubMed ID: 34012031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I.
    Boito CA; Melacini P; Vianello A; Prandini P; Gavassini BF; Bagattin A; Siciliano G; Angelini C; Pegoraro E
    Arch Neurol; 2005 Dec; 62(12):1894-9. PubMed ID: 16344347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Mouse Model of Limb-Girdle Muscular Dystrophy Type 2I Homozygous for the Common L276I Mutation Mimicking the Mild Phenotype in Humans.
    Krag TO; Vissing J
    J Neuropathol Exp Neurol; 2015 Dec; 74(12):1137-46. PubMed ID: 26574668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NAD+ improves neuromuscular development in a zebrafish model of FKRP-associated dystroglycanopathy.
    Bailey EC; Alrowaished SS; Kilroy EA; Crooks ES; Drinkert DM; Karunasiri CM; Belanger JJ; Khalil A; Kelley JB; Henry CA
    Skelet Muscle; 2019 Aug; 9(1):21. PubMed ID: 31391079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexually dimorphic skeletal muscle and cardiac dysfunction in a mouse model of limb girdle muscular dystrophy 2i.
    Maricelli JW; Kagel DR; Bishaw YM; Nelson OL; Lin DC; Rodgers BD
    J Appl Physiol (1985); 2017 Nov; 123(5):1126-1138. PubMed ID: 28663375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKRP mutations cause congenital muscular dystrophy 1C and limb-girdle muscular dystrophy 2I in Asian patients.
    Awano H; Saito Y; Shimizu M; Sekiguchi K; Niijima S; Matsuo M; Maegaki Y; Izumi I; Kikuchi C; Ishibashi M; Okazaki T; Komaki H; Iijima K; Nishino I
    J Clin Neurosci; 2021 Oct; 92():215-221. PubMed ID: 34509255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies.
    Chan YM; Keramaris-Vrantsis E; Lidov HG; Norton JH; Zinchenko N; Gruber HE; Thresher R; Blake DJ; Ashar J; Rosenfeld J; Lu QL
    Hum Mol Genet; 2010 Oct; 19(20):3995-4006. PubMed ID: 20675713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations alter secretion of fukutin-related protein.
    Lu PJ; Zillmer A; Wu X; Lochmuller H; Vachris J; Blake D; Chan YM; Lu QL
    Biochim Biophys Acta; 2010 Feb; 1802(2):253-8. PubMed ID: 19900540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients.
    Bourteel H; Vermersch P; Cuisset JM; Maurage CA; Laforet P; Richard P; Stojkovic T
    J Neurol Neurosurg Psychiatry; 2009 Dec; 80(12):1405-8. PubMed ID: 19917824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C.
    Brockington M; Yuva Y; Prandini P; Brown SC; Torelli S; Benson MA; Herrmann R; Anderson LV; Bashir R; Burgunder JM; Fallet S; Romero N; Fardeau M; Straub V; Storey G; Pollitt C; Richard I; Sewry CA; Bushby K; Voit T; Blake DJ; Muntoni F
    Hum Mol Genet; 2001 Dec; 10(25):2851-9. PubMed ID: 11741828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global FKRP Registry: observations in more than 300 patients with Limb Girdle Muscular Dystrophy R9.
    Murphy LB; Schreiber-Katz O; Rafferty K; Robertson A; Topf A; Willis TA; Heidemann M; Thiele S; Bindoff L; Laurent JP; Lochmüller H; Mathews K; Mitchell C; Stevenson JH; Vissing J; Woods L; Walter MC; Straub V
    Ann Clin Transl Neurol; 2020 May; 7(5):757-766. PubMed ID: 32342672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FKRP mutations, including a founder mutation, cause phenotype variability in Chinese patients with dystroglycanopathies.
    Fu X; Yang H; Wei C; Jiao H; Wang S; Yang Y; Han C; Wu X; Xiong H
    J Hum Genet; 2016 Dec; 61(12):1013-1020. PubMed ID: 27439679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional requirements for fukutin-related protein in the Golgi apparatus.
    Esapa CT; Benson MA; Schröder JE; Martin-Rendon E; Brockington M; Brown SC; Muntoni F; Kröger S; Blake DJ
    Hum Mol Genet; 2002 Dec; 11(26):3319-31. PubMed ID: 12471058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I.
    Thomas PJ; Xu R; Martin PT
    Am J Pathol; 2016 Sep; 186(9):2429-48. PubMed ID: 27561302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.